None listed
Conditions
Brief summary
To determine the effect of tele-nursing education and follow-up on self-efficacy and drug compliance to elderly cancer patients using oral anticancer drugs. The study aims to draw attention to tele-nursing practices, which have increased in importance in the world in recent years, by clearly defining the requirements related to tele-nursing, eliminating the obstacles and determining the strategies for competence. It is desired to contribute to the literature, to understand the limitations of previous studies and to guide future studies. This study is important in terms of providing evidence for nursing practices in the field and filling the gap in the follow-up of elderly patients using oral anticancer drugs in our country.
Interventions
The application of the research will be in the outpatient clinic of Gülhane Health Sciences University Medical Oncology Department. The research period is 12 weeks in total. The intervention will be performed by a specialist nurse with 9 years of experience. First Meeting with Patients (Face to Face) • Medication Adherence/Compliance Self-Efficacy Scale (MASES), Oral Chemotherapy Adherence Scale pre-test (first measurement) will be applied to the patients. • The first training with the patients will be in the form of face-to-face training. This training will be done by the researcher. Conduct of the first training session: verbal instruction.Due diligence will be made about what information patients need to improve adherence to oral anticancer drug and the causes of treatment adherence problems.This training will be given to the patients in line with the Education Manual for Patients Using Oral Anticancer Drugs prepared by the researcher. The overall duration of the meeting 45-60 minutes. • The patient's questions will be answered and it will be announced that the training will be started by telephone in order to reinforce the information given next week. Education with Tele-nursing (1st Week, 2nd Week, 3rd Week, 4th Week) • Patients will receive an educational video on their phone once a week for four weeks from the start of the study (The duration of the educational videos:1st video 1 minute 32 seconds, 2nd video 1 minute 35 seconds, 3rd video 3 minutes 27 seconds, 4th video 1 minute 48 seconds). • In the same week, 4 text messages will be sent to the patient about the training video. Length of text messages: Each message consists of 1-3 sentences. It takes an average of 20-30 second to read each message.There will be important points in the education booklet in the messages sent to the participants.Educational videos provided have been designed specifically for this study. •Of the four text messages to be sent each week, the 1st message will be sent on Monday, the 2nd message on Tuesday, the 3rd message on Wednesday and the fourth message on Thursday. The education video will be sent on Friday. Message ve education video it will be sent at 9 o'clock in the morning. • Messages and education videos will be sent from the WhatsApp application to monitor compliance with the intervention in patients. Messages and videos sent in this way will be evaluated according to the blue tick status. Follow-up with Tele-nursing (Week 5 - Week 12) • It will start in the 5th week after the completion of the trainings given over the phone and continue until the 12th week.From week 5 to week 12, a phone call will be made every week. • The content of tele-nursing will be shaped according to the patient. It will consist of questions that the patient does not understand in the messages and training videos, or the questions that the patient wants to ask about drug adherence. In addition, the researcher will focus on the issues that the patient has problems with in the use of oral anticancer drugs and suggestions will be made on these issues (for example: pain, nausea).The average duration of a weekly phone call is 5-15 minutes. •Intermediate measurement (second measurement) Drug Treatment Adherence/Compliance Self-Efficacy Scale (MASES), Oral Chemotherapy Compliance Scale will be administered to the patients at the 8th week by the researcher. At the end of the telephone follow-up (at the 12th week), the study will be concluded by applying the Drug Treatment Adherence/Compliance Self-Efficacy Scale (MASES), Oral Chemotherapy Compliance Scale and Tele-nursing evaluation form as a post-test (third measurement) to the patients.
Sponsors
Study design
Eligibility
Inclusion criteria
65 years and older, • Being diagnosed with cancer and knowing its diagnosis, • Having used at least one course of oral anticancer drugs, • Using any of the oral anticancer drugs (in addition to oral chemotherapy, patients who receive additional IV chemotherapy and/or radiotherapy treatment will also be included), • Having a telephone subscription and own telephone, • Able to communicate verbally and in writing over the phone, • Patients who agreed to participate in the study
Exclusion criteria
• Those who will not be able to communicate by phone, • Having poor general condition, • Having hearing, vision problems and cognitive problems that may prevent verbal and written communication, • Mini-Mental State Test total score below 24,